Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM) Selma B. SoutoEliana B. SoutoJosé L. Medina Review Article 06 April 2011 Pages: 653 - 661
Gastrointestinal safety of triflusal solution in healthy volunteers: a proof of concept endoscopic study Rosa M. AntonijoanIgnasi GichManel J. Barbanoj Clinical Trial 16 February 2011 Pages: 663 - 669
Pathophysiological idiosyncrasies and pharmacokinetic realities may interfere with tacrolimus dose titration in liver transplantation Itziar OteoJohn C. LukasRosario Calvo Clinical Trial 17 February 2011 Pages: 671 - 679
Relevance of a “Dear Doctor letter” to alert healthcare providers to new recommendations for vitamin D administration Hélène ThéophileGhada Miremont-SalaméFrançoise Haramburu Special Article 20 May 2011 Pages: 681 - 686
Distribution of mefloquine in the blood of Thai patients with acute uncomplicated falciparum malaria following administration of therapeutic doses of artesunate Kesara Na-BangchangRonnatrai RuengweerayutWalther H. Wernsdorfer Pharmacodynamics 10 May 2011 Pages: 687 - 691
Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer Troels K. BergmannHenrik GréenCurt Peterson Pharmacogenetics 16 February 2011 Pages: 693 - 700
Effects of SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of repaglinide in healthy Chinese volunteers Jiake HeZhixia QiuXijing Chen Pharmacogenetics 17 February 2011 Pages: 701 - 707
Lack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteers Daniel Y. NgSophie L. StockerRichard O. Day Pharmacokinetics and Disposition 23 December 2010 Pages: 709 - 713
Cytochrome P450 3A activity in mothers and their neonates as determined by plasma 4β-hydroxycholesterol Hanna NylénSofia SergelUlf Diczfalusy Pharmacokinetics and Disposition 19 January 2011 Pages: 715 - 722
The use of hypnosedative drugs in a university hospital: has anything changed in 10 years? Annemie SomersHugo RobaysMirko Petrovic Pharmacoepidemiology and Prescription 29 January 2011 Pages: 723 - 729
Psychotropic drug use in community-dwelling elderly people—characteristics of persistent and incident users Maria RikalaMaarit Jaana KorhonenSirpa Hartikainen Pharmacoepidemiology and Prescription 05 February 2011 Pages: 731 - 739
Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits Lina M. HellströmÅsa BondessonTommy Eriksson Pharmacoepidemiology and Prescription 12 February 2011 Pages: 741 - 752
Pharmacokinetics of caspofungin in a critically ill patient with liver cirrhosis Isabel SprietWouter MeerssemanLudo Willems Short Communication 03 June 2011 Pages: 753 - 755
Hyperkalaemia associated with hydroxyurea in a patient with polycythaemia vera Srecko MarusicNives Gojo-TomicVelimir Bozikov Letter to the Editors 14 December 2010 Pages: 757 - 758
